INGN vs JAZZ · rev $180.2M vs P/E 1988, rev $2.28B
Inogen Inc (INGN) versus Jazz Pharmaceuticals PLC (JAZZ) — a side-by-side from cached financials, not a winner call.
Inogen Inc (INGN) is a medical devices company listed on US.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Latest reported INGN revenue for 2026-06-30 was $180.2M. Net income was -$12.2M. INGN currently screens at market cap $173.5M.
Latest reported JAZZ revenue for 2026-06-30 was $2.28B. Net income was $485.9M. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
INGN currently screens at market cap $173.5M. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Not investment advice. Open the INGN and JAZZ stock pages for the full models.
Not investment advice.